Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Using a balloon guide catheter to improve clot removal for internal carotid artery stroke

Official title: Balloon Guide Catheter to Optimize Outcomes in Stroke Thrombectomy of the Internal Carotid Artery: a Randomized Controlled Trial

Run by Xuanwu Hospital, Beijing · NCT07192029 · Data updated 2026-11-12

This will test whether using a balloon guide catheter during mechanical thrombectomy helps people with acute ischemic stroke from an internal carotid artery blockage achieve better blood flow on the first pass.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment364 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations3 sites (Fuzhou, Fujian and 2 other locations)
StatusRecruiting
StartedOctober 12, 2025
Main results expectedAugust 31, 2026
Study endsDecember 31, 2026
Registry record updatedNovember 17, 2025
Trial IDNCT07192029 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with imaging-confirmed internal carotid artery occlusion causing acute ischemic stroke, NIHSS ≥6, within 24 hours of symptom onset and eligible for mechanical thrombectomy who can provide consent are ideal candidates.

Probably not a fit

Patients with pre-stroke disability (mRS >2), intracranial hemorrhage on imaging, occlusion due to dissection or atherosclerosis, or vascular anatomy that prevents device delivery are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with acute ischemic stroke caused by internal carotid artery occlusion and baseline NIHSS ≥6 who present within 24 hours are enrolled at multiple hospitals in Beijing and Fujian. Participants are assigned to receive either a balloon guide catheter with flow arrest or a standard guide catheter/neurovascular sheath as part of their mechanical thrombectomy procedure. The main outcome is the rate of first-pass expanded Thrombolysis in Cerebral Infarction (eTICI 2c-3) reperfusion. The trial compares reperfusion success between the two approaches to see if flow arrest with a balloon guide catheter improves immediate recanalization.

Why it matters

Potential benefit: If successful, using a balloon guide catheter could increase first-pass complete reperfusion rates, which may lead to faster recanalization and better recovery for patients.

How similar studies have gone: Observational and device-focused reports have suggested balloon guide catheters can improve reperfusion and reduce distal emboli, but randomized data specifically for internal carotid artery occlusions remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. age ≥18 years;
2. Clinical diagnosis of acute ischemic stroke with internal carotid artery occlusion confirmed by imaging (CTA/MRA/DSA), including isolated intracranial internal carotid artery (I-type), internal carotid artery intracranial segment involving middle cerebral artery (L-type), or internal carotid artery intracranial segment involving middle and anterior cerebral arteries (T-type) (including tandem embolic occlusions of the internal carotid artery C1 or common carotid artery);
3. Baseline NIHSS≥6, and meeting local guidelines for mechanical thrombectomy;
4. Time from onset or last known normal to randomization within 24 hours and proceeding to mechanical thrombectomy;
5. Signed informed consent (or by legal representative).

Exclusion Criteria:

1. Pre-stroke mRS score \>2
2. Intracranial hemorrhage shown on imaging;
3. Known or suspected internal carotid artery occlusion caused by dissection or atherosclerosis;
4. Vascular tortuosity preventing the use of balloon guide catheter;
5. Prior stent implantation in the target vessel that would impede the use or removal of mechanical thrombectomy devices;
6. Any other circumstances impeding mechanical thrombectomy implementation;
7. Acute occlusion of multiple vascular territories in bilateral anterior circulation or in both the anterior and posterior circulations confirmed by CTA/MRA;
8. Pregnant subjects;
9. Subjects allergic to contrast agents;
10. Subjects refusing to cooperate or unable to tolerate interventional procedures;
11. Subjects whose expected lifetime are less than 90 days;
12. Midline shift or herniation with ventricular mass effect;
13. Subjects deemed unable to participate in follow-up by investigators;
14. Other situations deemed unsuitable for balloon guide catheter use by investigators.

Where it's running

  • Fujian Medical University Union Hospital
    Fuzhou, Fujian, China
    Recruiting
  • Zhangzhou Municipal Hospital
    Zhangzhou, Fujian, China
    Recruiting
  • Xuanwu Hospital, Capital Medical University.
    Beijing, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.